GlassScriptPhysician profile
Artee Nanji
NPI 1164568358
$4,101.61
in general payments reported to CMS, 2019-2025
14 companies · $1,446 in 2025
The $1,446 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $34.97 · 2021: $293 · 2022: $220 · 2023: $819 · 2024: $855 · 2025: $1,446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,570 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $503 · Entertainment: $47.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,569.82 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $502.50 |
| Entertainment | $47.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $973.55 | 2025 | Optilight |
| Alcon Vision LLC | $825.13 | 2019-2025 | Total30, Precision 1, Precision7 |
| Coopervision INC. | $785.56 | 2020-2024 | Misight Contact Lens, Myday Contact Lens |
| Bausch & Lomb Americas INC. | $766.16 | 2023-2025 | Infuse, Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $189.84 | 2019-2021 | |
| Oyster Point Pharma, INC. | $139.56 | 2022 | |
| Maculogix, INC. | $94.00 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $92.61 | 2023-2024 | Acuvue |
| Lombart Brothers, INC. | $64.32 | 2025 | Opd-III |
| Sight Sciences, INC. | $56.69 | 2021-2022 | |
| Optos, INC. | $47.39 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Sun Pharmaceutical Industries INC. | $24.43 | 2022 | |
| Biotissue Holdings INC. | $23.04 | 2025 | |
| Allergan, INC. | $19.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Artee Nanji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.